How should the prostate-specific antigen (PSA), free PSA, and free PSA percentage be interpreted in a patient with a total PSA of 0.82 ng/mL, free PSA of 0.28 ng/mL, and free PSA percentage of 32.18%?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 18, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Your PSA Results Are Reassuring and Indicate Very Low Risk for Prostate Cancer

With a total PSA of 0.82 ng/mL, free PSA of 0.28 ng/mL, and free PSA percentage of 32.18%, you are at very low risk for prostate cancer and do not require prostate biopsy at this time.

Understanding Your Numbers

Total PSA (0.82 ng/mL)

Your total PSA is well below the traditional threshold of 4.0 ng/mL and even below more conservative age-specific cutoffs. According to NCCN guidelines, men with PSA levels below 1.0 ng/mL have an extremely low risk of prostate cancer—only 0.23% at 4 years and 0.49% at 8 years 1. Your value of 0.82 ng/mL places you in this very low-risk category.

For reference, the median PSA for men aged 40-49 is 0.7 ng/mL and for ages 50-59 is 0.9 ng/mL 1. Your level is within normal ranges regardless of your age group.

Free PSA Percentage (32.18%)

This is the most important number for assessing cancer risk when PSA is elevated. Your free PSA percentage of 32.18% is well above the concerning threshold and is actually protective against cancer risk.

Here's how to interpret free PSA percentage:

  • Below 10%: High concern for cancer 1
  • 10-15%: Moderate concern for cancer 2, 3
  • 15-25%: Lower concern, but still warrants evaluation if total PSA is elevated 4, 3
  • Above 25%: Very low cancer risk 2, 5

Your value of 32.18% is substantially above 25%, indicating benign conditions rather than cancer 2, 3. Research shows that men with PSA below 3.0 ng/mL and free PSA percentage above 18% have essentially no cancer risk at screening and remain at very low risk for at least 5 years 2.

What This Means Clinically

No Biopsy Needed

The combination of:

  1. Total PSA well below 1.0 ng/mL
  2. Free PSA percentage well above 25%

...definitively rules out the need for prostate biopsy 1, 2, 3.

Recommended Follow-Up Schedule

Based on NCCN guidelines, with your PSA below 1.0 ng/mL, you should have repeat PSA testing every 2 to 4 years 1. The specific interval depends on:

  • Younger age (45-55 years): Consider testing every 2 years
  • Older age (55-75 years) with stable low PSA: Can extend to every 4 years
  • Clinical judgment based on family history or other risk factors

Important Caveats

Free PSA percentage is most useful when total PSA is between 2.5-10.0 ng/mL 6, 4, 7. In your case with PSA of 0.82 ng/mL, the free PSA percentage provides additional reassurance but is somewhat less critical since your total PSA alone already indicates very low risk.

Factors that can affect PSA levels 8:

  • Prostatitis or urinary tract infection (increases PSA)
  • Recent prostate biopsy (wait 3-6 weeks before testing)
  • Finasteride or dutasteride (lowers PSA by ~50%)
  • Laboratory variability (20-25% variation between assays)

If you're taking finasteride or dutasteride, your actual PSA would be approximately double the measured value, but even doubled (1.64 ng/mL), this would still be reassuringly low.

Bottom Line

Your PSA profile is excellent. Continue routine screening at 2-4 year intervals based on your age and risk factors. No additional testing or intervention is needed at this time. The high free PSA percentage provides strong evidence against prostate cancer and suggests any PSA elevation is related to benign prostatic tissue rather than malignancy.

Related Questions

What is the significance of Prostate-Specific Antigen (PSA) total and free levels in prostate health?
In a 64‑year‑old man with a total PSA of 1.6 ng/mL and a free‑PSA percentage of 16 %, what is the appropriate workup?
What is the appropriate next step in management for a male patient with a total prostate‑specific antigen (PSA) of 6.5 ng/mL, free PSA of 0.73 ng/mL, and a free‑PSA percentage of 11.2%?
How should I manage a 76-year-old man with benign prostatic hyperplasia, a prostate volume of 53 cc, a total prostate‑specific antigen that rose from 2.5 ng/mL to 3.5 ng/mL over one year, and a free‑PSA fraction of 22 %?
What is the difference between serum prostate-specific antigen (total PSA), free prostate-specific antigen (free PSA), serum PSA titre, and serum free PSA titre?
Is there a pharmacologic treatment for life stressors in an otherwise healthy adult without bipolar disorder, substance misuse, or serious medical illness, and what first‑line medication would be recommended?
In an 83-year-old woman with a fungating breast cancer tumor, thrombocytosis and anemia (hemoglobin 8.9 g/dL), who declines surgical removal, what immediate palliative management should be pursued?
In a patient with a cough caused by lisinopril 10 mg daily, who is also taking hydrochlorothiazide 25 mg daily and bisoprolol fumarate 10 mg daily with a blood pressure of 130/78 mmHg and weight of 161 lb, how should the lisinopril be discontinued and hypertension be managed?
What are the causes of parkinsonism?
In an 89‑year‑old patient with a right basal pleural effusion receiving ampicillin‑sulbactam and clarithromycin, what additional intervention can be added to reduce the effusion?
What is the proper technique for intramuscular injection in the gluteal region and how should Nicolau syndrome be managed if it occurs?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.